What we've learned about epidemiology and vaccines in combating the pandemic

Coming up Monday at 9 a.m.

President Joe Biden visits the Viral Pathogenesis Laboratory at the NIH.
President Joe Biden greets Barney Graham, left, as he visits the Viral Pathogenesis Laboratory at the National Institutes of Health on Feb. 11 in Bethesda, Md. From left, Graham, Biden, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and Kizzmekia Corbett, an immunologist with the Vaccine Research Center at the NIH.
Evan Vucci | AP Photo file

How will the experience of vaccine development shape vaccine science beyond the pandemic? And how is the experience of the pandemic influencing scientific study of infectious diseases?

On Monday at 9 a.m., host Kerri Miller talks to an epidemiologist and a doctor working to increase immunization rates about the latest science, policy and lessons learned so far during the COVID-19 pandemic.


  • Dr. Kelly Moore is the deputy director of the Immunization Action Coalition, a group that works to increase immunization rates and prevent disease in support of recommendations by the Centers for Disease Control and Prevention.

  • Dr. Christine Petersen is the director of the Center for Emerging Infectious Diseases and a professor in the Department of Epidemiology at the University of Iowa.

Subscribe to the MPR News with Kerri Miller podcast on: Apple PodcastsGoogle PodcastsSpotify or RSS.

Your support matters.

You make MPR News possible. Individual donations are behind the clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives. Help ensure MPR remains a resource that brings Minnesotans together.